GenT framework aims to improve drug development with focus on entire genes, not individual mutations
Study identifies Ketorolac as a potential repurposable drug
Cleveland Clinic researchers receive $2 million grant from the National Institutes of Health
Virtual clinic supports oncologists by educating patients and making treatment recommendations
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement